BioMarin Pharmaceutical Inc. buy Sanford C. Bernstein
Start price
17.09.24
/
50%
€62.80
Target price
17.09.25
€80.87
Performance (%)
-26.54%
End price
18.09.25
€46.13
Summary
This prediction ended on 18.09.25 with a price of €46.13. The prediction for BioMarin Pharmaceutical Inc. disappointed with a performance of -26.54%. Sanford_C__Bernstein has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| BioMarin Pharmaceutical Inc. | -1.851% | -1.851% | -19.691% |
| iShares Core DAX® | 0.794% | 2.841% | 22.630% |
| iShares Nasdaq 100 | 0.016% | -0.939% | 6.943% |
| iShares Nikkei 225® | 0.309% | -0.648% | 13.619% |
| iShares S&P 500 | 0.181% | -0.442% | 4.692% |
Comments by Sanford_C__Bernstein for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its price target lowered by analysts at Sanford C. Bernstein from $116.00 to $90.00. They now have an "outperform" rating on the stock.
Ratings data for BMRN provided by MarketBeat
In the thread Trading BioMarin Pharmaceutical Inc.
Die von Sanford_C__Bernstein gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Sanford_C__Bernstein for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€85.64
20.08.24
20.08.24
€99.09
20.08.25
20.08.25
-42.16%
21.08.25
21.08.25
